Home -> Law Blog Directory -> Patent Law Blogs -> Philip Brooks’ Patent Infringement Updates
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Philip Brooks’ Patent Infringement UpdatesTeva Receives Favorable Court Decision Regarding Generic Temodar(R)
By Philip Brooks
The following is excerpted from a January 27, 2010 article at Medical News Today:
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. District Court for the District of Delaware has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Schering-Plough's brain tumor treatment Temodar® (temozolomide). The Court found that U.S. Patent No. 5,260,291 is not enforceable due to prosecution laches and inequitable conduct.
Teva's tentatively approved ANDA to market temozolomide is currently pending final approval at the U.S. Food and Drug Administration (FDA). As the first company to file the ANDA that contained a paragraph IV certification for Temodar®, Teva is eligible to receive 180-day Hatch-Waxman statutory exclusivity to market this product.
Annual sales of the brand product were approximately $369 million in the United States based on IMS sales data.
Full post as published by Philip Brooks’ Patent Infringement Updates on January 28, 2010 (boomark / email).
California Supreme Court Proposition 8 Decision
Court Rejects Challenges to Proposition 8, but Finds Marriages Valid
Selection of State Supreme Court Judges
How State Court Judges are Selected
Law Enforcement and Criminal Justice Career Choices
Descriptions of law enforcement occupations
Is Barack Obama a Natural Born Citizen?
Wrotnowski v. Bysiewicz (Supreme Court): Does Obama meet the constitutional requirements to be President
Heart of Atlanta v United States
Supreme Court Decision: Civil Rights Act Protected by Interstate Commerce Clause
Unwed Fathers' Rights in Adoption
Landmark Cases in Adoption Law Shape Law with respect to Unwed Fathers
Teva Animal Health Expands Ketamine Hydrochloride Recall
Teva Animal Health Expands Ketamine Hydrochloride Recall
ETHEX Corp
5 Generic Drugs Recalled Due to Risk of Death From Overdose
Poling Family Receives $1.5 Million in First Autism Vaccine Settlement
Poling Family Receives $1.5 Million in Autism Vaccine Settlement
Generic Versions
Barr Pharmaceuticals to pay $5.9 million settlement for blocking the sale of oral contraceptives.
Sprint
Receives Preliminary Approval of $17.5 Settlement for Early Termination Fees
Hazing Death
Phoummarath Family Receives $4.2 Million Settlement

Wyeth undercuts Teva on Protonix
"Appeals Court Decision Protects Pfizer's Celebrex From Generic Firm Teva Pharmaceutical"
Federal Circuit Affirms District Courts Extension of 30-Month FDA Stay
Teva Receives EU Marketing Authorization for G-CSF Biosimilar







